2022
DOI: 10.3934/mbe.2022432
|View full text |Cite
|
Sign up to set email alerts
|

FMR1 is identified as an immune-related novel prognostic biomarker for renal clear cell carcinoma: A bioinformatics analysis of TAZ/YAP

Abstract: <abstract> <p>WW domain-containing transcription regulator 1 (TAZ, or WWTR1) and Yes-associated protein 1 (YAP) are both important effectors of the Hippo pathway and exhibit different functions. However, few studies have explored their co-regulatory mechanisms in kidney renal clear cell carcinoma (KIRC). Here, we used bioinformatics approaches to evaluate the co-regulatory roles of TAZ/YAP and screen novel biomarkers in KIRC. GSE121689 and GSE146354 were downloaded from the GEO. The limma was ap… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 105 publications
0
1
0
Order By: Relevance
“…Charged multivesicular body protein 7 (CHMP7) has been shown to be a risk gene for squamous cell carcinoma of the head and neck (Chen et al 2022 ). Fragile X mental retardation 1 (FMR1) has been identified as a new immune-related prognostic biomarker for renal clear cell carcinoma (Wu et al 2022 ). In addition, FMR1 can promote the development of colorectal cancer cells by stabilizing EGFR mRNA (Hu et al 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…Charged multivesicular body protein 7 (CHMP7) has been shown to be a risk gene for squamous cell carcinoma of the head and neck (Chen et al 2022 ). Fragile X mental retardation 1 (FMR1) has been identified as a new immune-related prognostic biomarker for renal clear cell carcinoma (Wu et al 2022 ). In addition, FMR1 can promote the development of colorectal cancer cells by stabilizing EGFR mRNA (Hu et al 2022 ).…”
Section: Discussionmentioning
confidence: 99%